NUAK2, actif, humain étiqueté GST, PRECISIO Kinase, recombinant, exprimé en cellules bactériulovirus infectées Sf9 ,>=70% (SDS-PAGE), solution aqueuse tamponnée de glycérol

Code: srp5054-10ug D2-231

Non disponible en dehors du Royaume-Uni et de l'Irlande

General description

NUAK2 or SNF1/AMP kinase-related kinase (SNARK) is a member of the NUAK family of SNF1-like kinase 2. NUAK2 is activated by muscle contraction and is a un...


en savoir plus

Votre prix
$566.47 10UG

Non disponible en dehors du Royaume-Uni et de l'Irlande

General description

NUAK2 or SNF1/AMP kinase-related kinase (SNARK) is a member of the NUAK family of SNF1-like kinase 2. NUAK2 is activated by muscle contraction and is a unique mediator of contraction-stimulated glucose transport in skeletal muscle. NUAK2 is involved in cellular stress responses linked to obesity and type 2 diabetes. NUAK2 shows kinase activity against a synthetic test peptide and the activity in keratinocytes is increased by AMP and 5-amino-4-imidazolecarboxamide riboside, implying that AMPK kinase-dependent pathway can activate NAUK2. Glucose deprivation also increases NAUK2 activity in baby hamster kidney fibroblasts.

Legal Information

PRECISIO is a registered trademark of Sigma-Aldrich Co. LLC

Physical form

Supplied in 50mM Tris-HCl, pH 7.5, 150mM NaCl, 10mM glutathione, 0.1mM EDTA, 0.25mM DTT, 0.1mM PMSF, 25% glycerol.

Preparation Note

after opening, aliquot into smaller quantities and store at -70 °C. Avoid repeating handling and multiple freeze/thaw cycles

assay≥70% (SDS-PAGE)
formbuffered aqueous glycerol solution
Gene Informationhuman ... NUAK2(81788)
mol wt~110 kDa
NCBI accession no.NM_030952
product linePRECISIO® Kinase
recombinantexpressed in baculovirus infected Sf9 cells
shipped indry ice
specific activity68-92 nmol/min·mg
storage temp.−70°C
Ce produit répond aux critères suivants: